NUTX
Nutex Health, Inc. NASDAQ$147.17
Mkt Cap $876.3M
52w Low $77.21
60.4% of range
52w High $193.07
50d MA $102.98
200d MA $116.55
P/E (TTM)
12.5x
EV/EBITDA
4.3x
P/B
2.2x
Debt/Equity
1.1x
ROE
21.5%
P/FCF
4.5x
RSI (14)
—
ATR (14)
—
Beta
2.02
50d MA
$102.98
200d MA
$116.55
Avg Volume
209.5K
About
Nutex Health, Inc. operates as a technology-enabled healthcare services company. It operates through two divisions: Hospital division and Population Health Management division. The Hospital division implements and operates health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments. This division owns and operates 21 facilities in 8 states. The Populatio…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | AMC | 3.99 | 6.52 | +63.4% | 119.20 | +2.2% | +17.1% | — | — | — | — | — | — |
| Mar 5, 2026 | AMC | 5.56 | 1.61 | -71.0% | 105.34 | -15.5% | -14.3% | -6.4% | -8.1% | -14.1% | -17.4% | -4.5% | — |
| Nov 19, 2025 | AMC | 1.81 | 7.76 | +328.7% | 112.19 | +11.4% | +26.9% | +22.0% | +22.3% | +6.3% | +0.5% | +53.2% | — |
| Oct 8, 2025 | AMC | -5.43 | -3.02 | +44.3% | 102.74 | +1.0% | +0.9% | -7.7% | -0.6% | -3.2% | +3.2% | +11.6% | — |
| May 13, 2025 | AMC | 2.29 | 2.56 | +11.8% | 125.93 | +21.5% | +26.1% | +38.0% | +38.7% | +39.9% | +40.7% | -0.8% | — |
| Mar 31, 2025 | AMC | -0.12 | 11.12 | +9366.7% | 47.03 | +38.2% | +51.8% | +59.6% | +52.4% | +51.8% | +60.3% | +133.8% | — |
| Nov 8, 2024 | AMC | -0.24 | -1.72 | -616.7% | 31.56 | -0.0% | -11.6% | +19.0% | +3.3% | -0.7% | -9.1% | +21.0% | — |
| Aug 8, 2024 | AMC | -0.29 | -0.07 | +75.9% | 7.90 | +4.4% | +27.8% | +59.5% | +61.3% | +64.1% | +65.3% | +163.9% | — |
| May 8, 2024 | AMC | — | -0.10 | — | 6.47 | +4.0% | +2.0% | -2.5% | +8.0% | +9.7% | +11.0% | -5.3% | — |
| Mar 28, 2024 | AMC | — | -7.50 | — | 14.39 | +3.6% | -1.0% | -2.4% | -9.4% | -6.6% | -18.1% | -56.5% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 26 | Maxim Group | Maintains | Buy → Buy | — | $89.51 | $89.50 | -0.0% | +0.6% | +0.3% | -1.3% | -6.4% | -9.6% |
| Jul 10 | Benchmark | Maintains | Buy → Buy | — | $115.70 | $117.29 | +1.4% | +1.7% | -0.9% | +0.3% | -1.7% | -10.0% |
| May 20 | Maxim Group | Maintains | Buy → Buy | — | $176.21 | $178.36 | +1.2% | +0.6% | -4.1% | -8.1% | -9.2% | -7.1% |
| May 15 | Benchmark | Maintains | Buy → Buy | — | $158.80 | $162.67 | +2.4% | +9.4% | +10.0% | +11.0% | +11.6% | +6.4% |
| Apr 9 | Benchmark | Maintains | Buy → Buy | — | $84.94 | $87.80 | +3.4% | +22.2% | +35.1% | +55.4% | +52.7% | +63.6% |
| Apr 8 | Maxim Group | Maintains | Buy → Buy | — | $75.39 | $79.16 | +5.0% | +12.7% | +37.7% | +52.2% | +75.1% | +72.0% |
| Feb 13 | Maxim Group | Maintains | Buy → Buy | — | $58.30 | $58.49 | +0.3% | +15.5% | +13.3% | +13.2% | +11.1% | +5.7% |
| Nov 12 | Benchmark | Maintains | Buy → Buy | — | $27.91 | $30.00 | +7.5% | +34.6% | +16.8% | +12.3% | +2.8% | +0.7% |
| Nov 12 | Maxim Group | Maintains | Buy → Buy | — | $27.91 | $30.00 | +7.5% | +34.6% | +16.8% | +12.3% | +2.8% | +0.7% |
| Aug 21 | Benchmark | Maintains | Buy → Buy | — | $20.63 | $21.46 | +4.0% | -0.6% | +4.3% | +4.8% | +17.3% | +14.0% |
Recent Filings
8-K
Nutex Health Inc. -- 8-K Filing
I cannot write a meaningful investor analysis from this filing summary, as it contains only procedural/boilerplate language without substantive information about a material event or transaction.
Apr 23
8-K
Nutex Health Inc. -- 8-K Filing
Nutex Health reported full-year 2025 results for its hospital division and risk-bearing physician network, positioning itself as a consolidated healthcare operator spanning 27 facilities across 12 states.
Mar 5
8-K · 5.02
!!! Very High
Black Hawk Acquisition Corporation Class A -- 8-K 5.02: Executive Change
Black Hawk Acquisition Corp appointed Mitchell Creem as CFO and Frederick Woodruff Field as director, strengthening management ahead of potential merger completion or operational transition.
Feb 3
Data updated apr 26, 2026 4:10pm
· Source: massive.com